Results 91 to 100 of about 545 (126)
Some of the next articles are maybe not open access.

Management of Central Diabetes Insipidus

Best Practice & Research Clinical Endocrinology & Metabolism, 2020
The treatment of central diabetes insipidus has not changed significantly in recent decades, and dDAVP and replacement of free water deficit remain the cornerstones of treatment. Oral dDAVP has replaced nasal dDAVP as a more reliable mode of treatment for chronic central diabetes insipidus.
Aoife Garrahy, Christopher J Thompson
exaly   +3 more sources

DDAVP in the Treatment of Central Diabetes Insipidus

New England Journal of Medicine, 1976
DDAVP, 1-desamino-8-d-arginine-vasopressin, is a synthetic analogue of vasopressin with increased antidiuretic activity and decreased pressor activity. Whereas the antidiuretic-to-pressor ratio of arginine vasopressin is 1, the antidiuretic-to-pressor ratio of DDAVP is 4000.
Alan G. Robinson
exaly   +3 more sources

Central Diabetes Insipidus in Children and Young Adults

New England Journal of Medicine, 2000
Central diabetes insipidus is rare in children and young adults, and up to 50 percent of cases are idiopathic. The clinical presentation and the long-term course of this disorder are largely undefined.We studied all 79 patients with central diabetes insipidus who were seen at four pediatric endocrinology units between 1970 and 1996.
Maurizio Aricò   +2 more
exaly   +8 more sources

Neuroimaging of central diabetes insipidus

2021
Central diabetes insipidus (CDI) occurs secondary to deficient synthesis or secretion of arginine vasopressin peptide from the hypothalamo-neurohypophyseal system (HNS). It is characterized by polydipsia and polyuria (urine output >30mL/kg/day in adults and >2l/m2/24h in children) of dilute urine (
Terence Patrick, Farrell   +2 more
openaire   +2 more sources

Neurophysins in Central Diabetes insipidus

Hormone Research, 2008
When they were discovered by Acher and co-workers, neurophysins were thought to act as carriers for the active nonapeptides vasopressin (AVP) and oxytocin (OT) and were then recognized as the inactive fragment of a precursor with a higher molecular weight (propressophysin).
J J, Legros, V, Geenen
openaire   +2 more sources

The Diagnosis of Children with Central Diabetes Insipidus

Journal of Pediatric Endocrinology and Metabolism, 2007
Central diabetes insipidus is the end result of a number of different diseases that affect the hypothalamic-neurohypophyseal system. In many patients, especially children and young adults, it is caused by the destruction or degeneration of neurons that originate in the supraoptic and paraventricular nuclei of the hypothalamus. The known causes of these
GHIRARDELLO S   +3 more
openaire   +3 more sources

Central and Nephrogenic Diabetes Insipidus: Updates on Diagnosis and Management

open access: yesFrontiers in Endocrinology
Diabetes insipidus (DI) is a rare endocrine disease involving antidiuretic hormone (ADH), encompassing both central and nephrogenic causes. Inability to respond to or produce ADH leads to inability of the kidneys to reabsorb water, resulting in hypotonic
Kathryn Flynn   +4 more
exaly   +3 more sources

Central Diabetes Insipidus

Nihon rinsho. Japanese journal of clinical medicine, 2006
  +5 more sources

Central Diabetes Insipidus

The Endocrinologist, 1991
Patricia L. Bononi, Alan G. Robinson
openaire   +1 more source

Home - About - Disclaimer - Privacy